Shares of Dr. Reddy's Laboratories rallied nearly 10 per cent on the Bombay Stock Exchange after the drug maker said its facility at Vishakhapatnam received Establishment Inspection Report (EIR) from the US health regulator.
Buoyed by the development, shares of company gained as much as 9.70 per cent to touch an intra-day high of Rs 2498.00 apiece on the Bombay Stock Exchange.
In a similar fashion, shares of the firm were trading 3.22 per cent higher at Rs 2,347.75 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 33,522.46, up 162.56 points, or 0.49 per cent, at 11:45 hours.